Inside the CDMO Landscape: Factors Shaping Advanced Therapies Manufacturing
10 Feb 2026
Theatre 4
Commercial models & partnerships
In this presentation, we summarise the findings from our 2026 State of the Industry report, focussing on Advanced Therapies manufacturing. We will cover CDMO pricing trends, changes in sponsor-CDMO relationships, and how changes in the therapeutic pipeline are shaping the global advanced therapies manufacturing landscape, and what this might mean for both innovators and CDMOs in 2026 and beyond.
